ASSESSING THE NEUROPROTECTIVE POTENTIAL OF ZINGIBER OFFICINALIS METHANOL EXTRACT: A SHORT REVIEW
Main Article Content
Abstract
Background: Recent research has started to uncover the neuroprotective properties of ginger, specifically its methanol extract, suggesting that it may play a significant role in safeguarding neuronal cells against various forms of damage.
Methodology: The methodology involved evaluating in vitro and in vivo experimental studies that assessed the extract’s effects on neuronal cell lines, animal models of neurodegeneration and clinical observations. The review considered various parameters, including antioxidant activity, anti-inflammatory effects, and mechanisms of action related to neuroprotection.
Results: The findings indicate that Zingiber officinalis methanol extract possesses significant neuroprotective potential, attributed to its rich phytochemical composition, including gingerol, shogaol, and other bioactive compounds. In vitro studies demonstrated that the extract can reduce oxidative stress and inflammation in neuronal cells. In vivo studies provided evidence of improved cognitive function. The results suggest that Zingiber officinalis methanol extract may be a promising candidate for neuroprotective therapy. The mechanisms underlying its protective effects appear to involve the modulation of oxidative stress and inflammatory responses, as well as the enhancement of neurotrophic factor signaling.
Conclusion: Zingiber officinalis methanol extract exhibits significant neuroprotective properties, making it a candidate for further research in the context of neurodegenerative disease prevention and treatment.
Downloads
Article Details
Section
How to Cite
References
Abrahams, S., Haylett, W. L., Johnson, G., Carr, J. A., & Bardien, S. (2019). Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neuroscience, 406, 1–21.
Ajanaku, C. O., Ademosun, O. T., Atohengbe, P. O., Ajayi, S. O., Obafemi, Y. D., Owolabi, O. A., & Ajanaku, K. O. (2022). Functional bioactive compounds in ginger, turmeric, and garlic. Frontiers in Nutrition, 9, 1012023.
Arcusa, R., Villaño, D., Marhuenda, J., Cano, M., Cerdà, B., & Zafrilla, P. (2022). Potential role of ginger (Zingiber officinale Roscoe) in the prevention of neurodegenerative diseases. Frontiers in Nutrition, 9, 809621.
Alharbi, K. S., Nadeem, M. S., Afzal, O., Alzarea, S. I., Altamimi, A. S., Almalki, W. H., & Kazmi, I. (2022). Gingerol, a natural antioxidant, attenuates hyperglycemia and downstream complications. Metabolites, 12(12), 1274.
Ayustaningwarno, F., Anjani, G., Ayu, A. M., & Fogliano, V. (2024). A critical review of Ginger’s (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities. Frontiers in Nutrition, 11, 1364836.
Barua, C. C., Sharma, D., Devi, P. V., Islam, J., Bora, B., & Duarah, R. (2023). Nutraceuticals and bioactive components of herbal extract in the treatment and prevention of neurological disorders. In Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders (pp. 577–600). Academic Press.
Balogun, F. O., AdeyeOluwa, E. T., & Ashafa, A. O. T. (2019). Pharmacological potentials of ginger. Ginger Cultiv. Its Antimicrob. Pharmacol. Potentials, 10.
Ballester, P., Cerdá, B., Arcusa, R., Marhuenda, J., Yamedjeu, K., & Zafrilla, P. (2022). Effect of ginger on inflammatory diseases. Molecules, 27(21), 7223.
Choi, J. G., Kim, S. Y., Jeong, M., & Oh, M. S. (2018). Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders. Pharmacology & Therapeutics, 182, 56–69.
Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., & Zhang, L. (2024). PI3K/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression. Pharmacological Research, 107300.
Jain, K. K., & Jain, K. K. (2019). Neuroprotection in traumatic brain injury. In The Handbook of Neuroprotection (pp. 281–336).
Jafarzadeh, A., & Nemati, M. (2018). Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties. Journal of Neuroimmunology, 324, 54–75.
Kiyama, R. (2020). Nutritional implications of ginger: Chemistry, biological activities and signaling pathways. The Journal of Nutritional Biochemistry, 86, 108486.
Kou, X., Wang, X., Ji, R., Liu, L., Qiao, Y., Lou, Z., & Ho, C. T. (2018). Occurrence, biological activity and metabolism of 6-shogaol. Food & Function, 9(3), 1310–1327.
Lashgari, N. A., Momeni Roudsari, N., Khayatan, D., Shayan, M., Momtaz, S., Roufogalis, B. D., & Sahebkar, A. (2022). Ginger and its constituents: Role in treatment of inflammatory bowel disease. BioFactors, 48(1), 7–21.
Mao, Q. Q., Xu, X. Y., Cao, S. Y., Gan, R. Y., Corke, H., Beta, T., & Li, H. B. (2019). Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods, 8(6), 185.
Matin, M., Joshi, T., Wang, D., Tzvetkov, N. T., Matin, F. B., Wierzbicka, A., & Atanasov, A. G. (2024). Effects of Ginger (Zingiber officinale) on the Hallmarks of Aging. Biomolecules, 14(8).
Mohd Sahardi, N. F. N., & Makpol, S. (2019). Ginger (Zingiber officinale Roscoe) in the prevention of ageing and degenerative diseases: review of current evidence. Evidence-Based Complementary and Alternative Medicine, 2019(1), 5054395.
MS, K., & MR, A. (2024). Ginger revitalized: exploring the modern applications of Zingiber officinale in medicine and beyond. New Armenian Medical Journal, 18(3).
Nishanth, B. J., Vijayababu, P., & Kurian, N. K. (2023). Bacopa monnieri Extract As a Neuroprotective and Cognitive Enhancement Agent. International Journal of Drug Discovery and Pharmacology, 44–56.
Paolini Paoletti, F., Simoni, S., Parnetti, L., & Gaetani, L. (2021). The contribution of small vessel disease to neurodegeneration: focus on Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. International Journal of Molecular Sciences, 22(9), 4958.
Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019). Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics, 16(3), 666–674.
Talebi, M., Ilgün, S., Ebrahimi, V., Talebi, M., Farkhondeh, T., Ebrahimi, H., & Samarghandian, S. (2021). Zingiber officinale ameliorates Alzheimer’s disease and cognitive impairments: lessons from preclinical studies. Biomedicine & Pharmacotherapy, 133, 111088.
Vaou, N., Stavropoulou, E., Voidarou, C., Tsakris, Z., Rozos, G., Tsigalou, C., & Bezirtzoglou, E. (2022). Interactions between medical plant-derived bioactive compounds: focus on antimicrobial combination effects. Antibiotics, 11(8), 1014.
Xu, H., Wang, E., Chen, F., Xiao, J., & Wang, M. (2021). Neuroprotective phytochemicals in experimental ischemic stroke: mechanisms and potential clinical applications. Oxidative Medicine and Cellular Longevity, 2021(1), 6687386.
Zhang, M., Zhao, R., Wang, D., Wang, L., Zhang, Q., Wei, S., & Wu, C. (2021). Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents. Phytotherapy Research, 35(2), 711–742.